Aflac Incorporated (NYSE:AFL) Shares Sold by California Public Employees Retirement System

California Public Employees Retirement System lessened its position in Aflac Incorporated (NYSE:AFL) by 4.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 1,111,551 shares of the financial services provider’s stock after selling 47,316 shares during the period. California Public Employees Retirement System’s holdings in Aflac were worth $91,703,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. Fortitude Family Office LLC purchased a new position in Aflac during the fourth quarter worth about $25,000. Impact Partnership Wealth LLC raised its position in Aflac by 471.4% in the third quarter. Impact Partnership Wealth LLC now owns 400 shares of the financial services provider’s stock valued at $31,000 after purchasing an additional 330 shares during the period. Bruce G. Allen Investments LLC acquired a new position in shares of Aflac during the fourth quarter worth about $32,000. Harvest Fund Management Co. Ltd acquired a new position in shares of Aflac during the third quarter worth about $33,000. Finally, Criterion Capital Advisors LLC acquired a new stake in shares of Aflac in the fourth quarter valued at about $33,000. Hedge funds and other institutional investors own 67.44% of the company’s stock.

Insider Activity

In related news, Director Masatoshi Koide sold 30,493 shares of the firm’s stock in a transaction dated Friday, February 16th. The stock was sold at an average price of $79.91, for a total transaction of $2,436,695.63. Following the completion of the transaction, the director now owns 86,090 shares of the company’s stock, valued at $6,879,451.90. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other Aflac news, Director Masatoshi Koide sold 30,493 shares of the company’s stock in a transaction dated Friday, February 16th. The shares were sold at an average price of $79.91, for a total value of $2,436,695.63. Following the completion of the sale, the director now directly owns 86,090 shares of the company’s stock, valued at approximately $6,879,451.90. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, SVP Albert Riggieri sold 8,000 shares of the business’s stock in a transaction that occurred on Thursday, March 14th. The stock was sold at an average price of $83.34, for a total transaction of $666,720.00. Following the completion of the sale, the senior vice president now owns 32,825 shares in the company, valued at $2,735,635.50. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 46,493 shares of company stock worth $3,765,706. 0.80% of the stock is owned by company insiders.

Analyst Upgrades and Downgrades

Several equities analysts recently commented on the company. The Goldman Sachs Group boosted their price target on Aflac from $61.00 to $75.00 and gave the stock a “sell” rating in a research report on Tuesday, January 9th. Keefe, Bruyette & Woods upped their target price on shares of Aflac from $83.00 to $87.00 and gave the company a “market perform” rating in a research note on Wednesday, April 10th. Piper Sandler boosted their price objective on shares of Aflac from $90.00 to $95.00 and gave the stock an “overweight” rating in a report on Friday, April 5th. UBS Group increased their price objective on shares of Aflac from $80.00 to $84.00 and gave the company a “neutral” rating in a research note on Wednesday, January 10th. Finally, StockNews.com downgraded Aflac from a “hold” rating to a “sell” rating in a research note on Wednesday, April 10th. Three research analysts have rated the stock with a sell rating, eight have assigned a hold rating and three have issued a buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $82.15.

Aflac Price Performance

Shares of NYSE AFL opened at $84.29 on Thursday. The firm’s 50-day simple moving average is $82.53 and its 200 day simple moving average is $81.70. The stock has a market cap of $48.50 billion, a P/E ratio of 10.88, a P/E/G ratio of 2.29 and a beta of 0.91. The company has a quick ratio of 0.06, a current ratio of 0.06 and a debt-to-equity ratio of 0.33. Aflac Incorporated has a fifty-two week low of $64.10 and a fifty-two week high of $86.26.

Aflac (NYSE:AFL) last posted its quarterly earnings data on Thursday, February 1st. The financial services provider reported $1.25 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.47 by ($0.22). Aflac had a net margin of 24.92% and a return on equity of 17.59%. The company had revenue of $3.78 billion during the quarter, compared to the consensus estimate of $4.44 billion. During the same quarter last year, the business earned $1.29 earnings per share. Equities analysts expect that Aflac Incorporated will post 6.41 EPS for the current year.

Aflac Company Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.